NRD
PAHC icon

Nebula Research & Development’s Phibro Animal Health PAHC Stock Holding History

Nebula Research & Development’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,833
Closed -$583K – 622
2025
Q2 		$583K Buy
22,833
+2,739
+14% +$59.7K 0.05% 593
2025
Q1 		$429K Buy
20,094
+10,082
+101% +$225K 0.04% 652
2024
Q4 		$210K Buy
+10,012
New +$232K 0.02% 802
2024
Q1 		– Sell
-21,221
Closed -$246K – 926
2023
Q4 		$246K Buy
+21,221
New +$240K 0.07% 494

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nebula Research & Development's PAHC Position: Q3 2025 in Review

Nebula Research & Development sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 22,833 shares — an estimated $583K sold.

Nebula Research & Development first reported a position in PAHC in Q4 2023 and held it in 4 quarters. The position peaked at $583K in Q2 2025. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

  • Nebula Research & Development reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 22,833 Phibro Animal Health shares in Q3 2025, an estimated $583K.
  • Nebula Research & Development first reported a position in Phibro Animal Health in Q4 2023 and held it in 4 quarters.
  • Nebula Research & Development's Phibro Animal Health position peaked at $583K in Q2 2025.
  • 218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.